This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
2bk5
From Proteopedia
| Line 4: | Line 4: | ||
|PDB= 2bk5 |SIZE=350|CAPTION= <scene name='initialview01'>2bk5</scene>, resolution 1.83Å | |PDB= 2bk5 |SIZE=350|CAPTION= <scene name='initialview01'>2bk5</scene>, resolution 1.83Å | ||
|SITE= <scene name='pdbsite=AC1:Binding+Site+For+Residue+Fad+A+600'>AC1</scene>, <scene name='pdbsite=AC2:Binding+Site+For+Residue+Isn+A+601'>AC2</scene>, <scene name='pdbsite=AC3:Binding+Site+For+Residue+Fad+B+600'>AC3</scene> and <scene name='pdbsite=AC4:Binding+Site+For+Residue+Isn+B+601'>AC4</scene> | |SITE= <scene name='pdbsite=AC1:Binding+Site+For+Residue+Fad+A+600'>AC1</scene>, <scene name='pdbsite=AC2:Binding+Site+For+Residue+Isn+A+601'>AC2</scene>, <scene name='pdbsite=AC3:Binding+Site+For+Residue+Fad+B+600'>AC3</scene> and <scene name='pdbsite=AC4:Binding+Site+For+Residue+Isn+B+601'>AC4</scene> | ||
| - | |LIGAND= <scene name='pdbligand=FAD:FLAVIN-ADENINE+DINUCLEOTIDE'>FAD</scene> | + | |LIGAND= <scene name='pdbligand=FAD:FLAVIN-ADENINE+DINUCLEOTIDE'>FAD</scene>, <scene name='pdbligand=ISN:ISATIN'>ISN</scene> |
| - | |ACTIVITY= [http://en.wikipedia.org/wiki/Amine_oxidase_(flavin-containing) Amine oxidase (flavin-containing)], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.4.3.4 1.4.3.4] | + | |ACTIVITY= <span class='plainlinks'>[http://en.wikipedia.org/wiki/Amine_oxidase_(flavin-containing) Amine oxidase (flavin-containing)], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.4.3.4 1.4.3.4] </span> |
|GENE= | |GENE= | ||
| + | |DOMAIN= | ||
| + | |RELATEDENTRY=[[1gos|1GOS]], [[1h8r|1H8R]], [[1oj9|1OJ9]], [[1oja|1OJA]], [[1ojb|1OJB]], [[1ojc|1OJC]], [[1ojd|1OJD]], [[1s2q|1S2Q]], [[1s2y|1S2Y]], [[1s3b|1S3B]], [[1s3e|1S3E]], [[2bk3|2BK3]], [[2bk4|2BK4]] | ||
| + | |RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2bk5 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2bk5 OCA], [http://www.ebi.ac.uk/pdbsum/2bk5 PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=2bk5 RCSB]</span> | ||
}} | }} | ||
| Line 30: | Line 33: | ||
[[Category: Li, M.]] | [[Category: Li, M.]] | ||
[[Category: Mattevi, A.]] | [[Category: Mattevi, A.]] | ||
| - | [[Category: FAD]] | ||
| - | [[Category: ISN]] | ||
[[Category: fad]] | [[Category: fad]] | ||
[[Category: fad-containing amine oxidase]] | [[Category: fad-containing amine oxidase]] | ||
| Line 40: | Line 41: | ||
[[Category: transmembrane]] | [[Category: transmembrane]] | ||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Mar 31 02:07:35 2008'' |
Revision as of 23:07, 30 March 2008
| |||||||
| , resolution 1.83Å | |||||||
|---|---|---|---|---|---|---|---|
| Sites: | , , and | ||||||
| Ligands: | , | ||||||
| Activity: | Amine oxidase (flavin-containing), with EC number 1.4.3.4 | ||||||
| Related: | 1GOS, 1H8R, 1OJ9, 1OJA, 1OJB, 1OJC, 1OJD, 1S2Q, 1S2Y, 1S3B, 1S3E, 2BK3, 2BK4
| ||||||
| Resources: | FirstGlance, OCA, PDBsum, RCSB | ||||||
| Coordinates: | save as pdb, mmCIF, xml | ||||||
HUMAN MONOAMINE OXIDASE B: I199F MUTANT IN COMPLEX WITH ISATIN
Overview
Several reversible inhibitors selective for human monoamine oxidase B (MAO B) that do not inhibit MAO A have been described in the literature. The following compounds: 8-(3-chlorostyryl)caffeine, 1,4-diphenyl-2-butene, and trans,trans-farnesol are shown to inhibit competitively human, horse, rat, and mouse MAO B with K(i) values in the low micromolar range but are without effect on either bovine or sheep MAO B or human MAO A. In contrast, the reversible competitive inhibitor isatin binds to all known MAO B and MAO A with similar affinities. Sequence alignments and the crystal structures of human MAO B in complex with 1,4-diphenyl-2-butene or with trans,trans-farnesol provide molecular insights into these specificities. These inhibitors span the substrate and entrance cavities with the side chain of Ile-199 rotated out of its normal conformation suggesting that Ile-199 is gating the substrate cavity. Ile-199 is conserved in all known MAO B sequences except bovine MAO B, which has Phe in this position (the sequence of sheep MAO B is unknown). Phe is conserved in the analogous position in MAO A sequences. The human MAO B I199F mutant protein of MAO B binds to isatin (K(i) = 3 microM) but not to the three inhibitors listed above. The crystal structure of this mutant demonstrates that the side chain of Phe-199 interferes with the binding of those compounds. This suggests that the Ile-199 "gate" is a determinant for the specificity of these MAO B inhibitors and provides a molecular basis for the development of MAO B-specific reversible inhibitors without interference with MAO A function in neurotransmitter metabolism.
About this Structure
2BK5 is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
Demonstration of isoleucine 199 as a structural determinant for the selective inhibition of human monoamine oxidase B by specific reversible inhibitors., Hubalek F, Binda C, Khalil A, Li M, Mattevi A, Castagnoli N, Edmondson DE, J Biol Chem. 2005 Apr 22;280(16):15761-6. Epub 2005 Feb 14. PMID:15710600
Page seeded by OCA on Mon Mar 31 02:07:35 2008
